- About FSPH
- Current Students
- Prospective Students
- Alumni Affairs
- Give to the School
|Health Policy and Management|
Dr. Z. John Lu, adjunct associate professor in the Department of Health Policy and Management, is an expert in in pharmaceutical economics and the biopharmaceutical industry. He is the director of the UCLA Seminar on Pharmaceutical Economics and Policy.
The Seminar, now in its 32nd season, is the longest running seminar of its kind in the country. It has hosted hundreds of speakers from academia, industry, regulatory agencies, and representatives of the investor community, covering a wide range of topics such as cost of pharmaceutical R&D, branded firm strategic behavior, economic evaluation and value-based pricing of new drugs, international reference pricing, generic drug global supply chain, etc.
Dr. Lu has published extensively in pharmaceutical economics, including a recent major policy book: Pharmaceutical Economics and Policy: Perspectives, Promises, and Problems (co-authored with the late UCLA Professor Stuart Schweitzer; Oxford University Press, 2018).
Prior to joining academia, Dr. Lu was a health economist in the biopharmaceutical industry for two decades. He spent nearly 17 years (1994-2010) at Amgen where, as a director of global health economics, he led a team on economic evaluation and drug value demonstration, and provided expert advice on public policy discussions regarding the industry. He has also provided economic consulting services to numerous biopharmaceutical firms.
Dr. Lu is also a tenured associate professor of economics at the Martin V Smith School of Business and Economics, California State University, Channel Islands.